Skip to main content
. 2021 Sep 14;107(1):53–66. doi: 10.1210/clinem/dgab680

Table 1.

Clinical characteristics of study participants

Normal weight group (n = 118) Overweight
(n = 32)
Obese group
(n = 11)
P
No. (%) Mean (SD)/ Median
(Q1-Q3)
No. (%) Mean (SD)/ Median
(Q1-Q3)
No. (%) Mean (SD)/Median
(Q1-Q3)
Age, y 35.5 (3.7) 36.3 (3.8) 34.6 (3.8) .40a
Prepregnancy BMI 21.7 (1.7) 26.7 (1.3) 34.9 (5.1) < .001a
< .001b
< .001c
.001d
Systolic blood pressure first trimester, mm Hg 109.7 (12.3) 113.2 (9.0) 108.9 (8.9) .30a
Diastolic blood pressure first trimester, mm Hg 67.6 (9.0) 68.5 (8.2) 70.5 (7.0) .56a
Birthweight, g 3498 (415) 3654 (489) 3866 (550) .01a
.2b
.02c
.4d
Placenta weight, g 602 (131) 650 (155) 643 (110) .2a
Higher education
(> 12 y)
107
(90.7)
26
(81.3)
8
(72.7)
.2e
Infant sex male 64 (54.8) 19
(59.4)
6
(54.5)
.9e
Married or partner 116
(98.3)
30
(93.8)
10
(90.9)
.3e
Pregestational diabetes 0 0 0
Gestational diabetes 2
(1.7)
1
(3.1)
1
(9.1)
.2e
Gestational age, wk 39.3 (0.7) 39.3 (0.4) 39.4 (1.0) .9a
HMW adiponectin 3.0
(1.9-3.8)
2.2
(1.8-2.7)
2.5
(1.8-3.2)
.02f
.006g
.3h
.5i
Total adiponectin 5.3
(3.8-7.0)
4.1
(3.2-5.2)
4.5
(3.5-5.4)
.02f
.008g
.3h
.6i
HMW/total adiponectin ratio 0.55
(0.48-0.61)
0.50
(0.46-0.59)
0.52
(0.49-0.61)
.2f
Glucose, mmol/L 4.5 (0.4) 4.7 (0.4) 4.8 (0.7) .04a
.1b
.1c
.8d
Cholesterol, mmol/L 5.8 (1.0) 5.8 (1.3) 6.2 (1.0) .4a
Insulin, pmol/L 56.1
(35.5-75.9)
61.7
(43.7-93.3)
120.1
(92.0-137.8)
< .001f
.1g
< .001h
.004i

Abbreviations: BMI, body mass index; HMW, high molecular weight.

a One-way analysis of variance with Dunnett T3 post hoc test for comparison of the following:

b normal weight vs overweight groups;

c normal weight vs obese groups;

d overweight vs obese groups.

e Pearson chi-square.

f Kruskal-Wallis test with Bonferroni post hoc test for comparison of the following:

g normal weight vs overweight groups;

h normal weight vs obese groups;

i overweight vs obese groups.